A detailed history of Us Bancorp \De\ transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,460 shares of BHC stock, worth $10,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,460
Previous 1,860 21.51%
Holding current value
$10,789
Previous $12,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$5.22 - $8.26 $2,088 - $3,304
-400 Reduced 21.51%
1,460 $11,000
Q2 2024

Aug 06, 2024

SELL
$6.1 - $10.41 $768 - $1,311
-126 Reduced 6.34%
1,860 $12,000
Q1 2024

May 07, 2024

SELL
$7.77 - $10.61 $4,273 - $5,835
-550 Reduced 21.69%
1,986 $21,000
Q4 2023

Feb 09, 2024

SELL
$6.53 - $8.23 $14,052 - $17,710
-2,152 Reduced 45.9%
2,536 $20,000
Q3 2023

Nov 03, 2023

SELL
$7.69 - $9.71 $49,039 - $61,920
-6,377 Reduced 57.63%
4,688 $38,000
Q2 2023

Aug 09, 2023

SELL
$5.72 - $8.8 $7,590 - $11,677
-1,327 Reduced 10.71%
11,065 $88,000
Q1 2023

May 09, 2023

BUY
$6.28 - $9.85 $4,264 - $6,688
679 Added 5.8%
12,392 $100,000
Q4 2022

Feb 13, 2023

BUY
$6.09 - $7.93 $2,722 - $3,544
447 Added 3.97%
11,713 $73,000
Q3 2022

Oct 27, 2022

SELL
$4.58 - $9.21 $80,772 - $162,427
-17,636 Reduced 61.02%
11,266 $78,000
Q2 2022

Aug 01, 2022

BUY
$7.06 - $23.63 $46,151 - $154,469
6,537 Added 29.23%
28,902 $242,000
Q1 2022

May 11, 2022

BUY
$21.6 - $27.79 $190,101 - $244,579
8,801 Added 64.88%
22,365 $511,000
Q4 2021

Feb 11, 2022

SELL
$23.0 - $29.01 $215,441 - $271,736
-9,367 Reduced 40.85%
13,564 $374,000
Q3 2021

Nov 10, 2021

SELL
$25.04 - $30.06 $312,273 - $374,878
-12,471 Reduced 35.23%
22,931 $638,000
Q2 2021

Aug 05, 2021

SELL
$27.43 - $32.7 $6,116 - $7,292
-223 Reduced 0.63%
35,402 $1.04 Million
Q1 2021

Apr 28, 2021

BUY
$21.37 - $34.38 $244,686 - $393,651
11,450 Added 47.36%
35,625 $1.13 Million
Q4 2020

Feb 04, 2021

SELL
$15.31 - $21.12 $153,589 - $211,875
-10,032 Reduced 29.33%
24,175 $502,000
Q3 2020

Nov 10, 2020

BUY
$14.88 - $20.13 $32,810 - $44,386
2,205 Added 6.89%
34,207 $532,000
Q2 2020

Aug 07, 2020

BUY
$13.31 - $20.51 $68,453 - $105,482
5,143 Added 19.15%
32,002 $585,000
Q1 2020

May 13, 2020

BUY
$12.98 - $30.25 $4,620 - $10,769
356 Added 1.34%
26,859 $417,000
Q4 2019

Feb 04, 2020

BUY
$18.89 - $31.89 $80,981 - $136,712
4,287 Added 19.3%
26,503 $793,000
Q3 2019

Nov 08, 2019

SELL
$20.88 - $25.66 $1,378 - $1,693
-66 Reduced 0.3%
22,216 $485,000
Q2 2019

Aug 13, 2019

BUY
$20.52 - $26.45 $118,195 - $152,352
5,760 Added 34.86%
22,282 $562,000
Q1 2019

May 08, 2019

BUY
$20.23 - $26.29 $4,491 - $5,836
222 Added 1.36%
16,522 $408,000
Q4 2018

Feb 13, 2019

BUY
$17.64 - $28.32 $3,104 - $4,984
176 Added 1.09%
16,300 $301,000
Q3 2018

Nov 01, 2018

BUY
$20.64 - $25.67 $332,799 - $413,903
16,124 New
16,124 $414,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.